Biomedal is a biotechnology company that focuses on developing and commercializing new technologies, services, and products for research, bioindustry, and diagnostics. The company operates in two main areas: Biomedal Life Sciences and Biomedal Diagnostics. In the Life Sciences sector, the company specializes in the development and commercialization of products and services for life sciences research, as well as technology for industrial bioprocesses. It also functions as a CRO (Contract Research Organization), providing services and support to pharmaceutical or biotechnology companies. Biomedal Life Sciences has been successful in improving recombinant protein production through its own technology. On the other hand, Biomedal Diagnostics focuses on providing various products and services related to human health. The company has already made a mark in the market with its products for analysis related to immunological diseases and rapid tools for food safety analysis. Notably, it offers advanced gluten detection tests called Glutentox, capable of detecting the most immunogenic fraction of gluten. Additionally, Biomedal Diagnostics provides Oleotest, a rapid test kit for analyzing the quality of used frying oil. Founded in 2000, Biomedal is pioneering bioinnovation with its diverse offerings in the biotechnology and healthcare industries. The specific details regarding the company's headquarters, last investment, and investors are currently unspecified.
There is no investment information
No recent news or press coverage available for Biomedal.